Anne-Marie Koop

152 90. Joshi SR, Dhagia V, Gairhe S, Edwards JG, McMurtry IF, Gupte SA. Microrna-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the sugen5416/hypoxia/ normoxia model of pulmonary arterial hypertension. Am J Physiol - Hear Circ Physiol S.A. Gupte, Department of Pharmacology, New York Medical College, Valhalla, United States; 2016;311:H689–H698. 91. Peters EL, Offringa C, Kos D, Laarse WJ Van der, Jaspers RT. Regulation of myoglobin in hypertrophied rat cardiomyocytes in experimental pulmonary hypertension. Pflugers Arch Germany; 2016;468:1697–1707. 92. Sun X-Q, Zhang R, Zhang H-D, Yuan P, Wang X-J, Zhao Q-H, Wang L, Jiang R, Jan Bogaard H, Jing Z-C. Reversal of right ventricular remodeling by dichloroacetate is related to inhibition of mitochondria-dependent apoptosis. Hypertens Res Z.-C. Jing, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Disease, Peking Union Medical College, Chinese AcademyMedical Science, Beijing, China; 2016;39:302–311. 93. Bruggen CE Van Der, Happé CM, Dorfmüller P, Trip P, Spruijt OA, Rol N, Hoevenaars FP, Houweling AC, Girerd B, Marcus JT, Mercier O, Humbert M, Handoko ML, Velden J Van Der, Vonk Noordegraaf A, Bogaard HJ, Goumans M-J, Man FS De. Bone morphogenetic protein receptor type 2 mutation in pulmonary arterial hypertension: A view on the right ventricle. Circulation F.S. De Man, Department of Pulmonary Diseases, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, Netherlands; 2016;133:1747–1760. 94. Gupte AA, Cordero-Reyes AM, Youker KA, Matsunami RK, Engler DA, Li S, Loebe M, Ashrith G, Torre-Amione G, Hamilton DJ. Differential Mitochondrial Function in Remodeled Right and Nonremodeled Left Ventricles in Pulmonary Hypertension. J Card Fail D.J. Hamilton, Houston Methodist Hospital and Research Institute, Houston, United States; 2016; 22 :73–81. 95. Wang L, Li W, Yang Y, Wu W, Cai Q, Ma X, Xiong C, He J, Fang W. Quantitative assessment of right ventricular glucose metabolism in idiopathic pulmonary arterial hypertension patients: A longitudinal study. Eur Heart J Cardiovasc Imaging W. Fang, Department of Nuclear Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, FuWai Hospital, Beijing, China; 2016;17:1161–1168. 96. Sakao S, Daimon M, Voelkel NF, Miyauchi H, Jujo T, Sugiura T, Ishida K, Tanabe N, Kobayashi Y, Tatsumi K. Right ventricular sugars and fats in chronic thromboembolic pulmonary hypertension. Int J Cardiol S. Sakao, Department of Respirology (B2), Graduate School of Medicine, Chiba University, Chuo-ku, Chiba, Japan; 2016;219:143–149. 97. Ohira H, deKemp R, Pena E, Davies RA, Stewart DJ, Chandy G, Contreras-Dominguez V, Dennie C, Mc Ardle B, Mc Klein R, Renaud JM, DaSilva JN, Pugliese C, Dunne R, Beanlands R, Mielniczuk LM. Shifts in myocardial fatty acid and glucose metabolism in pulmonary arterial hypertension: a potential mechanism for a maladaptive right ventricular response. Eur Heart J Cardiovasc Imaging England; 2015; 98. Frille A, Steinhoff KG, Hesse S, Grachtrup S, Wald A, Wirtz H, Sabri O, Seyfarth H-J. Thoracic [18F]fluorodeoxyglucose uptake measured by positron emission tomography/computed tomography in pulmonary hypertension. Med (United States) A. Frille, Department of Respiratory Medicine, University of Leipzig, Leipzig, Germany; 2016;95. 99. Campos C, Luz de Castro A, Vicente Tavares AM, Fernandes RO, Ortiz VD, Barboza TE, Pereira C, Apel M, Santos da Silva O, Llesuy S, Sander da Rosa Araujo A, Belló-Klein A. Effect of free and nanoencapsulated copaiba oil on monocrotaline-induced pulmonary arterial